Last $7.05 USD
Change Today -0.12 / -1.67%
Volume 312.5K
INO On Other Exchanges
As of 5:20 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Niranjan Y. Sardesai Ph.D.

Chief Operating Officer, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Dr. Niranjan Y. Sardesai, PhD has been the Chief Operating Officer of Inovio Pharmaceuticals Inc since January 2012. Dr. Sardesai served as a Senior Vice President of Research & Development at Inovio Biomedical Corporation. from June 1, 2009 to December 2011. Dr. Sardesai served as Senior Vice President of Research & Development of VGX Pharmaceuticals, LLC from November 2007 to June 1, 2009. Dr. Sardesai served as Vice President of Product Development at VGX Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

Building 18
Blue Bell, Pennsylvania 19422

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

There is no Board Members Memberships data available.


California Institute of Technology
University of Pennsylvania - The Wharton School
IIT Council
Indian Institute of Technology, Bombay

Other Affiliations*

Annual Compensation*

Total Annual Compensation$409,764

Stock Options*

All Other Compensation$8,288
Exercisable Options661,860
Unexercisable Options277,500
Total Number of Options939,360

Total Compensation*

Total Annual Cash Compensation$418,052
Total Short Term Compensation$409,764
Other Long Term Compensation$8,288
Total Calculated Compensation$489,444
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $7.05 USD -0.12


Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at